Product Information
Name:EtDO-P4
Brand:Biosynth
Description:EtDO-P4 is a glucosylceramide synthase inhibitor which reduces the cellular levels of glucosylceramide (Glc-Cer) and the common biosynthetic precursor of most glycosphingolipids (GSLs). EtDO-P4 binds to the Glc-Cer synthase in a competitive manner and prevents the transfer of the first glucosyl residue, thus preventing further biosynthetic diversification into more elaborate glycosphingolipds. EtDO-P4 is a ceramide-like compound that was initially developed as a potential therapeutic for the treatment of diseases associated with altered glycosphingolipid levels. EtDO-P4 has also been used to indirectly increase sialylation levels in erythropoietin production. EtDO-P4 has been suggested, as part of compositions, for treatment of cardiac hypertrophy (Kwak, 2017).
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:516.76 g/mol
Formula:C31H52N2O4
Purity:Min. 95%
Technical inquiry about: EtDO-P4
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.